article thumbnail

Enabling the next wave of innovative drug therapies with speciality enzymes

Pharmaceutical Technology

For cell and gene therapy applications, you need a variety of speciality enzymes of the highest purity, specificity, and consistency. Developing best-in-class speciality enzymes. Novozymes has a long legacy of enzyme discovery and the ability to genetically engineer these speciality enzymes to be superior.

article thumbnail

Improve Your Health, Meet in Person

PM360

The health-conscious among us pay special attention to actively managing our sleep, exercise, vitamins, etc. Biopharma should pay special attention to this. You’re the gatekeeper of all communication on your platform, and participants are unlikely to network with one another independently. The list goes on. Here’s why.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

The PM360 Trailblazer Awards 2023 Winners

PM360

Men’s Health: Nuvan Augustin Dassanaike, Senior Vice President Digital and Marketing Strategy & Operations, Accord BioPharma Nephrology/Urology: W. Director, Obesity Market Access Strategy, Novo Nordisk Medical Device/Diagnostics: Brett Sarnoff, Vice President of Marketing Medical Device & Pharma Systems, North America, B.

Education 122
article thumbnail

Five IDNs to watch in 2023

Clarivate

healthcare provision landscape, integrated delivery networks, or IDNs, are differentiating their offerings by adding outpatient treatment centers, pursuing National Cancer Institute designations and investing in value-based care. In a fiercely competitive U.S. Christopher Silva, Senior Healthcare Research Analyst.

article thumbnail

The potential of AI in pharma R&D

Pharmaceutical Technology

Learn about how AI is helping companies right now, what to know about its benefits and challenges, and what’s needed to implement AI in biopharma research. They created neural networks that found multiple antibiotics from millions of candidates. According to Deloitte , 76% of biopharma companies invest in AI for clinical development.

Pharma 52
article thumbnail

The Caregiver Vertical: How Pharma Engages

Pharma Marketing Network

Sunny White is an Editorial Advisory Board member for the Pharma Marketing Network with unique insights into how important caregivers are to the HCP/patient relationship and overall health outcomes. Sunny’s healthcare marketing agency, Xavier Creative House, specializes in pharmaceutical, biotech, and medical device. Sunny White.

Pharma 98
article thumbnail

PM360 Announces 2023 Trailblazer Award Finalists

PM360

Now, Real Chemistry is at the forefront of applying analytics, data, and artificial intelligence to the biopharma and healthcare industry and, in 2022, the company achieved its 21st consecutive year of double-digit growth. Weiss has also made substantial efforts to give back to the community at large. Braun Medical, Inc.